| New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer A Dongre, RA Weinberg Nature reviews Molecular cell biology 20 (2), 69-84, 2019 | 2901 | 2019 |
| Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas A Dongre, M Rashidian, F Reinhardt, A Bagnato, Z Keckesova, HL Ploegh, ... Cancer research 77 (15), 3982-3989, 2017 | 340 | 2017 |
| Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells M Rashidian, JR Ingram, M Dougan, A Dongre, KA Whang, C LeGall, ... Journal of Experimental Medicine 214 (8), 2243-2255, 2017 | 207 | 2017 |
| IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization Z Castano, BP San Juan, A Spiegel, A Pant, MJ DeCristo, T Laszewski, ... Nature cell biology 20 (9), 1084-1097, 2018 | 146 | 2018 |
| Inflammation triggers Zeb1-dependent escape from tumor latency JM De Cock, T Shibue, A Dongre, Z Keckesova, F Reinhardt, ... Cancer research 76 (23), 6778-6784, 2016 | 139 | 2016 |
| Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade M Rashidian, MW LaFleur, VL Verschoor, A Dongre, Y Zhang, TH Nguyen, ... Proceedings of the National Academy of Sciences 116 (34), 16971-16980, 2019 | 107 | 2019 |
| Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia JE Roderick, G Gonzalez-Perez, CA Kuksin, A Dongre, ER Roberts, ... Journal of Experimental Medicine 210 (7), 1311-1329, 2013 | 94 | 2013 |
| Non-Canonical Notch Signaling Drives Activation and Differentiation of Peripheral CD4+ T Cells A Dongre, L Surampudi, RG Lawlor, AH Fauq, L Miele, TE Golde, ... Frontiers in immunology 5, 54, 2014 | 93 | 2014 |
| Direct and indirect regulators of epithelial–mesenchymal transition–mediated immunosuppression in breast carcinomas A Dongre, M Rashidian, EN Eaton, F Reinhardt, P Thiru, M Zagorulya, ... Cancer discovery 11 (5), 1286-1305, 2021 | 87 | 2021 |
| Inadequate DNA damage repair promotes mammary transdifferentiation, leading to BRCA1 breast cancer H Wang, D Xiang, B Liu, A He, HJ Randle, KX Zhang, A Dongre, N Sachs, ... Cell 178 (1), 135-151. e19, 2019 | 69 | 2019 |
| Low energy electron induced damage to plasmid DNA pQE30 SVK Kumar, T Pota, D Peri, AD Dongre, BJ Rao The Journal of Chemical Physics 137 (4), 2012 | 28 | 2012 |
| Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer S Ortiz-Cuaran, A Swalduz, JP Foy, S Marteau, AP Morel, F Fauvet, ... European Journal of Cancer 169, 106-122, 2022 | 17 | 2022 |
| the role of the EMT program in regulating the immune response in carcinoma A Dongre, S Ortiz-Cuaran, H Korkaya Frontiers in immunology 13, 940164, 2022 | 4 | 2022 |
| Leveraging immunochemotherapy for treating pancreatic cancer A Dongre, RA Weinberg Cell Research 31 (12), 1228-1229, 2021 | 3 | 2021 |
| Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition I O’Connell, A Dongre Molecular Diagnosis & Therapy 27 (4), 433-444, 2023 | 1 | 2023 |
| 232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade A Dongre, R Weinberg, M Rashidian, E Eaton, F Reinhardt, P Thiru, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| Targeting mesenchymal tumor cell-intrinsic factors sensitizes refractory tumors to immune checkpoint blockade therapy KM Bakhle, CH Sams, A Dongre Cancer Research 84 (6_Supplement), 6556-6556, 2024 | | 2024 |
| Targeting epithelial-mesenchymal plasticity and CD73 to enhance responses of breast cancers to immune checkpoint blockade therapies A Dongre CANCER RESEARCH 84 (3), 2024 | | 2024 |
| Abstract B022: Targeting epithelial-mesenchymal plasticity and CD73 to enhance responses of breast cancers to immune checkpoint blockade therapies A Dongre Cancer Research 84 (3_Supplement_1), B022-B022, 2024 | | 2024 |
| Targeting Hypoxia‐Adenosinergic Signaling to Enable Effective Anti‐Tumor Responses by Reprogramming the Immunosuppressive Tumor Microenvironment K Beattie, NR Romero Navarrete, A Dongre, M Sitkovsky, S Hatfield The FASEB Journal 36, 2022 | | 2022 |
Robert A. WeinbergMITGeverifieerd e-mailadres voor wi.mit.edu
